Status: Recruiting
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
This study is being conducted to characterize the safety, tolerability, and efficacy of AP306 at fixed doses in adults with hyperphosphatemia receiving maintenance hemodialysis.
Participants needed: 168
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: R1 TherapeuticsUpdated: Jul 13, 2026Locations: 31
Eligibility criteria
Signs a written informed consent form (ICF) and is willing to comply with all st... [+6]
Pregnant or breastfeeding [+14]